In August 2024, we decided to end Andwise, with no formal press release, no dramatic pivot tweets, just a resolve to shut it down before becoming something we never intended to.
Andwise began because we saw doctors like Ananya about to sign their first job contract with all the subtle landmines hidden in the fine print. Ananya was a PGY-3 with looming student loan bills and no real legal training. She could handle twelve-hour shifts and the emotional weight of patient care, but a contract’s tail coverage, non-competes, and moonlighting clauses were terrifyingly opaque. Her experience was common: most physicians step out of residency financially and legally disarmed. Meanwhile, their employers, lenders, and insurers know exactly how to exploit the knowledge gap.
We tried to build a platform that gave doctors actual clarity: a contract analyzer to highlight terms that could lock them into bad deals, student loan tools that connected with servicers and surfaced better repayment or refinancing options, and a “Physician-Friendliness” score so they could avoid advisors who offered kickbacks rather than real guidance. Alongside the tools, we ran a growing set of free workshops, a newsletter called Fiscal Therapy, and a podcast we called Know Scrubs, so physicians could share insights with each other free from marketing agendas.
From the outset, we refused referral fees or sponsored placements. We did that because we believed doctors needed an unbiased tool, and we never treated it as a branding tactic. For a while, it worked. Residents said we were the first platform that actually helped them parse a contract in plain English. Some doctors saved hundreds a month on loan payments thanks to the dashboards we built.
And the feedback we got (hearing that a PGY-2 who was drowning in debt finally felt safe and informed) fed our conviction that we were filling a real gap.
But there’s an obvious cost to staying this brashly principled. We were lean to the point of running on fumes. Potential investors, though initially entranced by the “help doctors help themselves” mission, eventually wanted us to monetize fear. They suggested funneling anxious residents into tiered plans or pushing them toward whichever advisor gave us bigger affiliate fees. We sat in meetings where we were told we needed to “layer in urgency,” cut corners on transparency, and basically prey on the same vulnerability we were trying to protect.
Around the time these investor conversations grew more strained, I was also diagnosed as autistic. Suddenly, compromising on tactics that manipulated users’ anxieties or “harvested” their trust in sneaky ways felt even more impossible to me. It was an ethical stance, and it was also how I was wired. The more we tried to blend standard startup growth strategies with our vow of neutrality, the more tension we created with our own existence.
At some point, I realized that sustaining Andwise on the usual venture track meant betraying the very reason we started. Rather than cross that line, we shut down. We turned out the lights in August 2024, without fanfare, out of respect for what it had meant to the people who used it.
We didn’t scale. But we didn’t morph into another fear-based funnel, either. We helped hundreds of physicians understand contract terms, made it easier to ask tough financial questions, and gave them a place to speak honestly without being sold to. Then we stopped on our own terms.
I don’t consider that a neat success story, nor do I see it as a clean failure. It’s a refusal story. In a system that monetizes illusions and runs on short-lived trust, we said no.
And yes, it still hurts that Andwise is gone. I know doctors still desperately need what we tried to provide. The roadmap was real: from Match Day toolkits for interns to advanced financial planning for mid-career docs to a line of credit bridging the gap before a new resident’s first paycheck. We had a thorough vision of how doctors could keep more of their autonomy and break free from a system that preys on them. That vision just didn’t mesh with the typical growth demands that keep startups afloat.
If you’re building a similarly principled venture, or you’re a doctor who felt seen by what we did, take this much from it: sometimes shutting down is the clearest way to stay true to what you set out to do. The refusal still feels like the right call.
If any piece of Andwise’s blueprint helps someone else carry the torch in a way that respects doctors’ intelligence and dignity, I’ll be cheering from the sidelines, still believing in what we started.
The joinandwise.com site will sunset soon. But its premise, that clarity and care are still worth building for, lives on. Most of what I write at syadvada.com now zooms out: how systems filter and exclude, how trust is commodified, how design can either enable refusal or remove it.
Andwise was my zoomed-in version of that same project, built as a counterexample.
- Kanav Jain Co-founder & CEO, Andwise (Closed August 2024)
Postscript, August 2026. Two years on, I’d tell this story with less romance and more structure. “Investors wanted us to monetize fear, so we refused” is true, but it compresses four separate facts. The product hypothesis held: physicians used Andwise and kept using it. The business model never resolved: adoption alone did not prove the product could be financed in a way that preserved what it was for. The monetization paths most likely to fund continued growth (tiered plans, referral fees, urgency mechanics) would have made physician fear the revenue engine and someone other than the physician the economic customer. And the shutdown was a capital-allocation decision, not a moral flourish: once the question stopped being “can we keep the company alive?” and became “what company would we have to become to keep it alive?”, continuing was no longer justified.
The refusal framing above makes it sound like the system failed us. The structural version admits what I got wrong: I had assumed that if we created enough value for physicians, a compatible business model would eventually become available. It didn’t follow. A product can create real value and still lack a financing structure that preserves the relationships behind its value. Aligning the beneficiary, the user, and the economic buyer is a design problem in its own right, and has to be solved before adoption makes the answer expensive. That lesson, more than the refusal, is what Andwise bought. The essay stands as written; this is what it looks like from further away.